Correction to: Multidisciplinary Clinical Care in the Management of Patients Receiving Anti‑GD2 Immunotherapy for High‑Risk Neuroblastoma

Detalles Bibliográficos
Autores principales: Cabral, Jennifer, Fernandez, Erica I., Toy, Bonnie, Secola, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931770/
https://www.ncbi.nlm.nih.gov/pubmed/36692687
http://dx.doi.org/10.1007/s40272-023-00557-y
_version_ 1784889306349830144
author Cabral, Jennifer
Fernandez, Erica I.
Toy, Bonnie
Secola, Rita
author_facet Cabral, Jennifer
Fernandez, Erica I.
Toy, Bonnie
Secola, Rita
author_sort Cabral, Jennifer
collection PubMed
description
format Online
Article
Text
id pubmed-9931770
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-99317702023-02-17 Correction to: Multidisciplinary Clinical Care in the Management of Patients Receiving Anti‑GD2 Immunotherapy for High‑Risk Neuroblastoma Cabral, Jennifer Fernandez, Erica I. Toy, Bonnie Secola, Rita Paediatr Drugs Correction Springer International Publishing 2023-01-24 2023 /pmc/articles/PMC9931770/ /pubmed/36692687 http://dx.doi.org/10.1007/s40272-023-00557-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Cabral, Jennifer
Fernandez, Erica I.
Toy, Bonnie
Secola, Rita
Correction to: Multidisciplinary Clinical Care in the Management of Patients Receiving Anti‑GD2 Immunotherapy for High‑Risk Neuroblastoma
title Correction to: Multidisciplinary Clinical Care in the Management of Patients Receiving Anti‑GD2 Immunotherapy for High‑Risk Neuroblastoma
title_full Correction to: Multidisciplinary Clinical Care in the Management of Patients Receiving Anti‑GD2 Immunotherapy for High‑Risk Neuroblastoma
title_fullStr Correction to: Multidisciplinary Clinical Care in the Management of Patients Receiving Anti‑GD2 Immunotherapy for High‑Risk Neuroblastoma
title_full_unstemmed Correction to: Multidisciplinary Clinical Care in the Management of Patients Receiving Anti‑GD2 Immunotherapy for High‑Risk Neuroblastoma
title_short Correction to: Multidisciplinary Clinical Care in the Management of Patients Receiving Anti‑GD2 Immunotherapy for High‑Risk Neuroblastoma
title_sort correction to: multidisciplinary clinical care in the management of patients receiving anti‑gd2 immunotherapy for high‑risk neuroblastoma
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931770/
https://www.ncbi.nlm.nih.gov/pubmed/36692687
http://dx.doi.org/10.1007/s40272-023-00557-y
work_keys_str_mv AT cabraljennifer correctiontomultidisciplinaryclinicalcareinthemanagementofpatientsreceivingantigd2immunotherapyforhighriskneuroblastoma
AT fernandezericai correctiontomultidisciplinaryclinicalcareinthemanagementofpatientsreceivingantigd2immunotherapyforhighriskneuroblastoma
AT toybonnie correctiontomultidisciplinaryclinicalcareinthemanagementofpatientsreceivingantigd2immunotherapyforhighriskneuroblastoma
AT secolarita correctiontomultidisciplinaryclinicalcareinthemanagementofpatientsreceivingantigd2immunotherapyforhighriskneuroblastoma

Ejemplares similares